BeStock  
Stocks › Biotechnology › CTMX

CytomX CTMX

US equityMarket cap rank #3673Biotechnology
$2.55 −$0.01 (-0.39%)
Pre-market · Oct 8, 8:20 am ET · After hours $2.54 -0.39%
Open$2.53
Prev close$2.56
Day range$2.52 – $2.65
Volume2.34M
Market cap$555.64M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.42M-92.4% YoY
Operating profit-$23.78M-1,749.2% YoY
Net profit-$20.67M-13,319.5% YoY
Diluted EPS-$0.09
Free cash flow-$18.07M-14.5% YoY
Operating cash flow-$18.07M

Revenue, last 8 quarters

$33.4MSep '24$38.1MDec '24$50.9MMar '25$18.7MJun '25$6.0MSep '25$663.0KDec '25$10.3MMar '26$1.4MJun '26

Net profit, last 8 quarters

$5.7MSep '24$18.9MDec '24$23.5MMar '25$-154.0KJun '25$-14.2MSep '25$-26.5MDec '25$-18.2MMar '26$-20.7MJun '26

Diluted EPS by quarter

0.07Sep '240.23Dec '240.27Mar '250.00Jun '25-0.09Sep '25-0.22Dec '25-0.10Mar '26-0.09Jun '26

Free cash flow by quarter

$-20.7MSep '24$-20.0MDec '24$-21.2MMar '25$-15.8MJun '25$-15.4MSep '25$-23.4MDec '25$-25.5MMar '26$-18.1MJun '26

Annual revenue

$68.4MFY20$37.3MFY21$53.2MFY22$101.2MFY23$138.1MFY24$76.2MFY25

Profitability & balance sheet

Operating margin-476.2%
Net margin-435.2%
Return on equity-37.8%
Return on assets-28.6%
Return on invested capital-38.8%
Current ratio9.36
Liabilities / assets20.8%
Cash & investments$330.28M
Total debt$4.21M
Net cash (debt)$326.07M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.42M $10.26M $76.20M $663,000.00 $5.96M
Total Operating Revenue $1.42M $10.26M $76.20M $663,000.00 $5.96M
Operating Expense $25.20M $29.93M $98.57M $28.60M $21.73M
Selling and Admin Expenses $7.60M $10.69M $29.84M $7.36M $6.43M
-General & Admin Expense $7.60M $10.69M $29.84M $7.36M $6.43M
Research & Development $17.60M $19.24M $68.73M $21.24M $15.30M
Operating Profit -$23.78M -$19.67M -$22.36M -$27.93M -$15.77M
Net Non-Operating Interest Income (Expense) $3.16M $1.49M $5.21M $1.48M $1.59M
Non-Operating Interest Income $3.16M $1.49M $5.21M $1.48M $1.59M
Other Income (Expense) $18,000.00 -$7,000.00 $28,000.00 -$5,000.00 $5,000.00
Other Non-Operating Income (Expenses) $18,000.00 -$7,000.00 $28,000.00 -$5,000.00 $5,000.00
Pretax Profit -$20.61M -$18.19M -$17.13M -$26.46M -$14.17M
Tax $60,000.00 $59,000.00 $238,000.00 $54,000.00 $58,000.00
Net Profit -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
Profit from Continuing Operations -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
Net Income to Parent Company -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
Net Income to Common Stockholders -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
Basic EPS -$0.09 -$0.10 -$0.15 -$0.22 -$0.09
Diluted EPS -$0.09 -$0.10 -$0.15 -$0.22 -$0.09

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $381.23M $359.36M $151.57M $151.57M $158.25M
Total Current Assets $373.16M $353.10M $143.92M $143.92M $149.22M
Cash and Cash Equivalents & Short-Term Investments $330.28M $346.71M $137.05M $137.05M $143.63M
-Cash and Cash Equivalents $17.22M $28.83M $12.67M $12.67M $34.19M
-Short Term Investments $313.06M $317.88M $124.39M $124.39M $109.44M
Receivables $37.49M $646,000.00 $2.01M $2.01M $1.63M
-Accounts Receivable $37.49M $646,000.00 $2.01M $2.01M $1.63M
Restricted Cash $917,000.00 – – – –
Other Current Assets $4.46M $5.74M $4.86M $4.86M $3.96M
Total Non-Current Assets $8.07M $6.26M $7.65M $7.65M $9.04M
Net PPE $6.12M $3.35M $4.70M $4.70M $6.54M
-Gross PPE $6.12M $3.35M $21.62M $21.62M $6.54M
Goodwill and Other Intangible Assets $1.31M $1.35M $1.39M $1.39M $1.42M
-Goodwill $949,000.00 $949,000.00 $949,000.00 $949,000.00 $949,000.00
-Other Intangible Assets $365,000.00 $401,000.00 $438,000.00 $438,000.00 $474,000.00
Other Non-Current Assets $641,000.00 $1.56M $1.56M $1.56M $1.08M
Total Liabilities $79.16M $39.41M $52.56M $52.56M $50.87M
Total Current Liabilities $39.86M $34.02M $46.62M $46.62M $41.03M
Payables $1.94M $1.37M $1.30M $1.30M $646,000.00
-Accounts Payable $1.94M $1.37M $1.30M $1.30M $646,000.00
Current Accrued Expenses $12.35M $11.92M $14.20M $14.20M $12.41M
Short-Term Debt and Capital Lease Obligation $1.50M $2.86M $4.24M $4.24M $5.60M
-Current Capital Lease Obligation $1.50M $2.86M $4.24M $4.24M $5.60M
Current Deferred Liabilities $24.07M $17.88M $26.88M $26.88M $22.38M
Total Non-Current Liabilities $39.30M $5.39M $5.94M $5.94M $9.84M
Long Term Debt and Capital Lease Obligation $4.21M – $0.00 $0.00 $0.00
-Long Term Capital Lease Obligation $4.21M – $0.00 $0.00 $0.00
Non-Current Deferred Liabilities $30.62M $979,000.00 $1.59M $1.59M $5.54M
Other Non-Current Liabilities $4.47M $4.41M $4.35M $4.35M $4.30M
Total Equity $302.07M $319.94M $99.01M $99.01M $107.39M
Stockholders' Equity $302.07M $319.94M $99.01M $99.01M $107.39M
Capital Stock $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00
-Common Stock $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.05B $1.05B $810.84M $810.84M $789.72M
Retained Earnings -$750.86M -$730.20M -$711.95M -$711.95M -$682.44M
Gains/Losses Not Affecting Retained Earnings -$196,000.00 $102,000.00 $111,000.00 $111,000.00 $104,000.00
-Accumulated Depreciation – – -$16.92M -$16.92M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$18.07M -$25.55M -$75.59M -$23.24M -$15.55M
Net cash flow from continuing operations -$18.07M -$25.55M -$75.59M -$23.24M -$15.55M
Net Income from Continuing Operations -$20.67M -$18.25M -$17.37M -$26.51M -$14.23M
Depreciation & Depletion & Amortization $47,000.00 $251,000.00 $1.38M $510,000.00 $134,000.00
Other Non-Cash Items $1.37M $1.13M $4.48M $1.16M $1.13M
Change in Working Capital $37,000.00 -$12.66M -$68.58M $434,000.00 -$3.33M
-Change in Receivables -$36.85M $1.37M $1.09M -$384,000.00 $240,000.00
-Change in Prepaid Assets -$2.86M -$887,000.00 -$1.24M -$874,000.00 $708,000.00
-Change in Payables and Accrued Expense $3.91M -$3.53M -$2.83M $1.14M $93,000.00
-Change In Other Working Capital $35.84M -$9.61M -$65.60M $551,000.00 -$4.38M
Net cash flow from investing $5.95M -$192.78M -$59.74M -$14.42M $439,000.00
Net Cash Flow from Continuing Investing Activities $5.95M -$192.78M -$59.74M -$14.42M $439,000.00
Net PPE Purchase and Sale $0.00 $0.00 -$220,000.00 -$201,000.00 $127,000.00
Net Investment Purchase and Sale $5.95M -$192.78M -$59.52M -$14.22M $312,000.00
Financing Cash Flow $511,000.00 $234.49M $110.45M $16.64M $253,000.00
Net Cash Flow from Continuing Financing Activities $511,000.00 $234.49M $110.45M $16.64M $253,000.00
Net Common Stock Issuance $56,000.00 $228.35M $109.64M $16.26M $0.00
Proceeds from Stock Option Exercised $455,000.00 $6.14M $811,000.00 $381,000.00 $253,000.00
Ending Cash Balance $18.75M $30.36M $14.19M $14.19M $35.21M
Net Change in Cash -$11.60M $16.16M -$24.89M -$21.02M -$14.86M
Beginning Cash Balance $30.36M $14.19M $39.08M $35.21M $50.07M
Free Cash Flow -$18.07M -$25.55M -$75.81M -$23.44M -$15.42M

Discussion

No comments yet — be the first to weigh in on CTMX.

Leave a comment

Scroll to Top